ArticleCell death & disease2022

Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression.

Pablo Carabias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.